# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also rais...
Needham analyst Laura Martin reiterates Roku (NASDAQ:ROKU) with a Buy and maintains $100 price target.
Benchmark analyst Daniel Kurnos reiterates Roku (NASDAQ:ROKU) with a Buy and maintains $105 price target.
Wolfe Research analyst Peter Supino upgrades Roku (NASDAQ:ROKU) from Peer Perform to Outperform and announces $93 price target.
Fans can find NFL games and more via the NFL Zone all season longThe NFL Zone is back on the Roku platform in the U.S., just in...
Wells Fargo analyst Steven Cahall upgrades Roku (NASDAQ:ROKU) from Underweight to Equal-Weight and raises the price target f...